Bloodwork & longevity telehealth
Which panel to get first, what each one measures, and what happens after the results.
15 providers offer this. 11 include labs in the price. 0 accept insurance. Figures reflect what each provider publishes. * = provisional score.
Highest-scored providers
People focused on nutrition and fitness optimization who want a periodic blood panel with algorithmic recommendations and no prescribing.
Read the review → #2
OneTwenty 9.9 People who want their blood retested every 90 days (a 101-marker baseline plus three follow-up panels a year) and want custom supplements and prescriptions, at published prices, driven by those results in one membership.
Read the review → #3
Quest Health 9.9 People who want a one-off or occasional broad blood panel at a Quest draw site, priced per test, without signing up for a membership.
Read the review →Ranked guides
All providers
| Clinic | Score | Consult | Labs | Prescriber | Insurance | From |
|---|---|---|---|---|---|---|
| A blood-biomarker and wearable-data platform producing personalised nutrition and lifestyle recommendations. Testing and insights, not treatment. | 10.0 | — | Included | MD/DO | — | $489 first year |
| Bloodwork-led longevity and hormone optimisation telehealth, with physician-guided TRT, GLP-1 weight management and peptide therapy built on comprehensive lab panels. | 9.9 | — | Included | — | Cash | $499/yr membership |
| Quest Diagnostics' consumer site selling physician-ordered lab tests and health-profile panels (up to 85+ markers) per test, drawn at Quest sites, with no membership. | 9.9 | — | Included | — | Cash | $199 one-time |
| An annual-membership lab-testing service running a very large biomarker panel with physician-written results summaries. Testing and insights, not treatment. | 9.8 | — | Included | — | Cash | $365/yr |
| An annual-membership health platform combining a broad lab panel with a clinician-reviewed action plan. | 9.6 | Async | Included | MD/DO + NP/PA | Cash | $199/yr |
| A longevity medicine membership combining quarterly at-home blood draws, telehealth clinician consults and prescriptions for hormones, GLP-1s and cardiometabolic drugs. | 9.1 | Hybrid | Included | MD/DO + NP/PA | — | $199 first month |
| A monthly subscription at-home blood test (25+ biomarkers, Tasso+ collection) run in its own lab, with results and an AI coach but no clinical care or prescribing. | 9.1 | — | Included | — | Cash | $79/month |
| SiPhox Health An at-home finger-free blood collection kit service that tests a chosen biomarker panel monthly, quarterly or every six months, with no prescribing. | 9.0 | — | Included | — | Cash | $124 per at-home test kit |
| Marek Health Also offers A telehealth clinic built around comprehensive bloodwork and physician-guided hormone optimisation, with TRT, peptide therapy and GLP-1 programmes. Known for an unusually deep lab panel. | 7.0 | Hybrid | Extra | MD/DO + NP/PA | Cash | $299 |
| A functional-medicine telehealth clinic offering bloodwork-driven hormone optimisation, TRT, peptide therapy and GLP-1 weight loss. | 6.9 | Video | Included | — | Cash | $125/mo Core care plan |
| A $9-a-month membership marketplace that sells lab panels, at-home kits and scans at published member prices, with clinician review of results for members. | 6.4 | — | Extra | — | Cash | $9/mo or $99/yr membership |
| An at-home and in-lab testing company whose Everlywell 360 annual membership includes one 83-biomarker Quest blood panel, with an optional clinician consult that can prescribe. | 8.4* | — | Included | MD/DO + NP/PA | Cash | $399/yr Everlywell 360 membership |
| A large men’s hormone telehealth provider offering at-home lab testing, TRT and enclomiphene protocols, with a subscription model and physician video consults. | 6.2* | Video | Extra | MD/DO | Cash | $65 initial lab test |
| A men’s preventive-health telehealth provider combining comprehensive bloodwork with TRT and sexual health treatment under a physician. | 5.1* | Video | Extra | MD/DO + NP/PA | Cash | $95/mo |
| Labcorp's consumer site selling provider-ordered lab tests and panels (up to 65+ markers) per test, drawn at Labcorp sites or by home kit, with no membership. | Not scored | — | Included | — | Cash | $399 one-time |
Head-to-head comparisons
Tools for this decision
What these clinics prescribe
Reference records for the compounds offered in this category. Mechanism, dosing ranges, evidence level and regulatory status for each.
- Gonadorelin — Synthetic gonadotropin-releasing hormone, increasingly used alongside TRT to maintain testicular function.
- hCG — A placental glycoprotein hormone that mimics LH directly at the testis, the long-standing standard for preserving fertility on TRT.
- Semaglutide — A long-acting GLP-1 receptor agonist and the compound that reset expectations for pharmacological weight loss.
- Sermorelin — The first 29 amino acids of endogenous growth-hormone-releasing hormone, and the shortest fragment that retains full biological activity.
- Tesamorelin — A stabilised GHRH analog and the only growth-hormone secretagogue with a current FDA approval for a body-composition indication.
- Tirzepatide — A dual GIP and GLP-1 receptor agonist that produced greater weight loss than semaglutide in head-to-head trial data.
References
Regulatory and primary sources
- CMS: Clinical Laboratory Improvement Amendments (CLIA) ↗ · federal standards for clinical labs
- HHS: Telehealth for patients ↗ · what to expect from a telehealth visit
- FDA: BeSafeRx, buying medicine online safely ↗ · how to check an online pharmacy
- NABP: Safe.Pharmacy verified websites ↗ · pharmacy accreditation lookup
- FSMB DocInfo: physician license lookup ↗ · check a prescriber is licensed
- FTC: Endorsements, influencers and reviews ↗ · disclosure rules for affiliate links
Published literature
- Direct-to-consumer genetic testing.BMJ 2019.PubMed 31619392 · doi:10.1136/bmj.l5688
- Direct-to-Consumer Genetic Testing.NEJM Evid 2025.PubMed 41147825 · doi:10.1056/EVIDra2400455
- Direct-to-Consumer Testing: Benefits and Concerns of Commercially Accessed Laboratory Tests.Clin Chem 2025.PubMed 39964351 · doi:10.1093/clinchem/hvaf004
- Home sperm testing-increasing uses for direct-to-consumer tests.Fertil Steril 2023.PubMed 36502933 · doi:10.1016/j.fertnstert.2022.12.010
- Direct-to-Consumer Genetic Testing: Value and Risk.Annu Rev Med 2021.PubMed 32735764 · doi:10.1146/annurev-med-070119-114727
- Direct-to-consumer pharmacogenomic testing.Pharmacogenomics 2011.PubMed 22008043 · doi:10.2217/pgs.11.100
- Direct-to-Consumer Testing.Clin Chem 2017.PubMed 27993938 · doi:10.1373/clinchem.2016.260349
- Direct to consumer testing, drugs and gifts.Bioethics 2020.PubMed 32100331 · doi:10.1111/bioe.12734
Literature retrieved from PubMed on October 18, 2026, favouring human studies and reviews. Numbered markers in the text show which paper supports which statement; uncited entries are background reading.